Search
dihydrotestosterone (androstanolone) in serum/plasma
Indications:
- monitoring 5-alpha-reductase inhibitor therapy for benign prostatic hypertrophy
- evaluating possible 5-alpha-reductase deficiency
Reference interval: Adult Male >19 years: 112-955 pg/mL Adult Female 20-55 years: < 300 pg/mL Adult Female >55 years: < 128 pg/mL
Method:
- Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Related
stanolone; dihydrotestosterone (DHT); androstanolone; 5-alpha androstan-17-beta-ol-3-one
Specific
dihydrotestosterone (androstanolone) free in serum/plasma
dihydrotestosterone (androstanolone) in serum/plasma post challenge
General
dihydrotestosterone (androstanolone) in body fluid
References
- Mayo Clinic Laboratories: Dihydrotestosterone, Serum
http://www.mayomedicallaboratories.com/test-catalog/Overview/81479